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The immune response is crucial for protection against disease; however, immunological imbalances can lead to 
heart and digestive tract lesions in chagasic patients. Several studies have evaluated the cellular and humoral im-
mune responses in chagasic patients in an attempt to correlate immunological findings with clinical forms of Chagas 
disease. Moreover, immunoglobulins and cytokines are important for parasitic control and are involved in lesion 
genesis. Here, cytokine and IgG isotype production were studied, using total epimastigote antigen on sera of chagasic 
patients with indeterminate (IND, n = 27) and cardiac (CARD, n = 16) forms of the disease. Samples from normal, 
uninfected individuals (NI, n = 30) were use as controls. The results showed that sera from both IND and CARD 
patients contained higher levels of Trypanosoma cruzi-specific IgG1 (IgG1) antibodies than sera from NI. No differ-
ence in IgG2 production levels was observed between NI, IND and CARD patients, nor was a difference in IL-10 and 
IFN-γ production detected in the sera of IND, CARD and NI patients. However, IND patients displayed a positive 
correlation between IL-10 and IFN-γ levels in serum, while CARD patients showed no such correlation, indicating an 
uncontrolled inflammatory response in CARD patients. These findings support the hypothesis that a lack of efficient 
regulation between IFN-γ and IL-10 productions in CARD patients may lead to cardiac immunopathology.
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It is well accepted that the host’s immune response 
plays a key role during Trypanosoma cruzi infection, 
leading to either parasite control during the acute phase 
or to participation in the pathology development during 
the chronic phase (Dutra & Gollob 2008). Antibody pro-
duction and T-cell responses have been studied in patients 
with Chagas disease (Morgan et al. 1996, Cordeiro et al. 
2001) and experimental models (Giordanengo et al. 2000, 
Guedes et al. 2008). Mononuclear cells from the heart tis-
sue or peripheral blood of patients with the cardiac form 
of the disease produce higher IFN-γ and TNF-α and lower 
or absent production of IL-10 and IL-4 compared with 
asymptomatic individuals (Correa-Oliveira et al. 1999, 
Ribeirao et al. 2000, Gomes et al. 2003). However, other 
studies have shown that the mean levels of mRNA expres-
sion for IL-5, IL-10, IL-13 and IFN-γ were dramatically 
increased in peripheral blood mononuclear cells (PBMCs) 
freshly isolated from chagasic patients, regardless of the 
clinical form, compared to uninfected individuals (NI) 
(Dutra et al. 1997). Furthermore, the authors observed no 
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significant differences in cytokine levels between cells 
from cardiac (CARD) and indeterminate patients (IND) 
upon stimulation with parasite-derived antigens (epi-
mastigote and trypomastigote) (Dutra et al. 1997).
Similarly, cytokine levels in the sera from CARD 
and IND patients were analyzed and contradictory re-
sults were obtained. Higher TNF-α (Ferreira et al. 2003, 
Talvani et al. 2004) and NO levels (Perez-Fuentes et al. 
2007) were observed in the plasma of chagasic CARD 
patients with the severe form of the disease, compared 
to patients with mild cardiopathy and NI. These results 
suggest a role for systemic NO and TNF-α in dilated car-
diomyopathy. In contrast, no difference was observed in 
cytokine levels in the sera of chagasic patients with dif-
ferent clinical outcomes. IL-2, IFN-γ, and TNF-α pro-
duction were similar in all groups of chagasic patients 
with different forms of the disease (Ward et al. 1999). 
These results were confirmed by other studies, which 
also showed that, although the levels of TNF-α and NO 
were higher in sera from chagasic patients, compared to 
non-chagasic individuals, no difference was observed 
between asymptomatic and symptomatic chagasic pa-
tients (Perez-Fuentes et al. 2008). IFN-γ levels were sim-
ilar in the sera of asymptomatic individuals and CARD 
patients that presented the form of the disease (Ribeirao 
et al. 2000). Thus, the findings of several studies have 
failed to clearly establish a correlation between the con-
centration of circulating cytokines and the cardiac form 
of Chagas disease. 
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Studies concerning antibody production during the 
chronic phase of Chagas disease have focused on the 
analysis of IgG isotypes. Differences in the biological 
properties of these antibodies may have an important 
effect on the natural history of Chagas disease. More-
over, the production of different antibody isotypes is 
controlled by distinct cytokines. In chronic chagasic 
patients, IgG1 and IgG2 form about 90% of the IgG 
produced (Watthanakulpanich et al. 2008). It has been 
demonstrated that Th1 cytokines (IL-12, IFN-γ, TNF-α) 
are responsible for the production of IgG1 and IgG3 iso-
types, while Th2 cytokines (IL-4 and IL-10) stimulate 
IgG2 production (Briere et al. 1994, Kawano et al. 1994). 
IgG1 mediates lysis binding to complement C1q protein 
and macrophage phagocytosis, while IgG2 mediates im-
munity by non-phagocytic effectors cells (Fanger et al. 
1991). Correlation between the different clinical forms 
of Chagas disease and the levels of IgG isotypes has not 
been clearly defined. Several authors have tried to dem-
onstrate the correlation between IgG isotypes and the 
severity of the different clinical forms of Chagas disease 
both in patient groups (Cerban et al. 1993, Morgan et 
al. 1996, Michailowsky et al. 2003) and in experimental 
models (Giordanengo et al. 2000, Guedes et al. 2008). 
While some studies detected no differences between the 
levels of these immunoglobulins (IgG) among individu-
als with different clinical manifestations (Cerban et al. 
1993, Michailowsky et al. 2003), others demonstrated 
higher levels of IgG2 antibodies in the sera of patients 
with cardiac and digestive manifestations of the disease 
(Morgan et al. 1996, Cordeiro et al. 2001).
The aim of the present study was to analyze the lev-
els of IL-10, IFN-γ and anti-T. cruzi antibody (IgG1 and 
IgG2 isotypes) production and determine the possible 
usefulness of these cytokines and antibodies as immu-
nological markers of clinical evolution in the sera of 
chagasic IND and CARD patients with clinical forms 
of the disease. Correlation analysis between regulatory 
and inflammatory cytokine production in CARD and 
IND patients was performed to improve the current un-
derstanding of the immunoregulation involved in patho-
logical development in human Chagas disease. Analysis 
of the results showed an imbalanced immune response 
in CARD patients, suggesting that an uncontrolled im-
mune response is associated with cardiac disease.
PATIENTS AND METHODS
Patients - The inclusion of all subjects in the present 
investigation was approved by two independent Ethi-
cal Committees [Universidade Federal de Minas Gerais 
(087/99), Belo Horizonte, Minas Gerais, and Hospital 
São Salvador, Goiânia, Goiás, Brazil]. Signed, informed 
consent forms were obtained from the participants. All 
patients (n = 43) showed positive serology for Chagas 
disease, as determined by ELISA and immunofluores-
cence tests (Camargo 1966). The patients were from en-
demic areas in Brazil. The data (number, sex, age and 
clinical form) are summarized in Table. Based on their 
clinical records, the chagasic patients were divided into 
two different groups, IND and CARD. Patients present-
ing asymptomatic T. cruzi infection, classified as IND 
(n = 27), presented no clinical manifestations of the 
disease other than their positive serology. Patients with 
cardiac dysfunction (n = 16) presented with dilated car-
diomyopathy and were identified via a detailed clini-
cal examination, including electrocardiogram, chest X-
ray, Holter and echodopplercardiography. Sera from NI 
(n = 30) were obtained from seronegative healthy inhab-
TABLE
Age, sex and clinical forms of chronic chagasic patients 
from states of Minas Gerais, Goiás and Mato Grosso, central 
region of Brazil
Patient  Age Clinical
number Sex (years)  form
1  F 27 IND
2  M 51 IND
3  M 45 CARD
4  F 33 IND
5  M 33 IND
6  F 27 IND
7  F 39 IND
8  M 25 IND
9  M 44 CARD
10  F 46 IND
11  F 54 CARD
12  F 49 CARD
13  F 54 IND
14  F 35 CARD
15  F 31 CARD
16  F 37 IND
17  F 26 IND
18  F 44 IND
19  F 43 IND
20  F 33 IND
21  F 20 IND
22  M 30 IND
23  M 42 IND
24  F 22 IND
25  M 30 IND
26  M 38 IND
27  F 35 IND
28  F 53 IND
29  F 33 CARD
30  M 42 IND
31  F 44 IND
32  F 40 IND
33  M 50 CARD
34  M 75 IND
35  M 57 CARD
36 M 45 CARD
37  F 39 CARD
38  F 50 CARD
39  F 59 CARD
40  M 25 CARD
41  M 57 CARD
42  M 76 IND
43  F 47 CARD
CARD: cardiac; F: female; IND: indeterminate; M: male.
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itants of the same endemic areas. Normal individuals 
did not differ from Chagas disease patients with regard 
to age or gender. 
Conventional serology (ELISA) - Peripheral blood 
was collected and maintained at 4oC for 30 min to 
promote clot formation. Serum samples were stored 
at -80°C prior to cytokine quantification. ELISA tests 
were performed according to the methods of Voller et 
al. (1976). Briefly, ELISA plates were sensitized with T. 
cruzi antigen prepared by alkaline extraction of the Y 
strain, obtained by exponential growth in LIT medium. 
The sera were added to the plates and antibody bind-
ing was detected using peroxidase-labeled anti-human 
IgG. Total IgG or IgG1 and IgG2 isotypes conjugated to 
horseradish peroxidase (Bethyl Laboratories, Montgo-
mery, USA) were used to determine antibody levels. The 
plates were read in a spectrophotometer using a 490 nm 
filter (BIO-RAD, 3550). The cut-off was determined us-
ing the mean absorbance of 10 NI individuals plus two 
standard deviations.
Cytokine quantification (ELISA) - Cytokine levels 
in the sera were determined by ELISA. The ELISA sets 
were IL-10 and IFN-γ (R & D Duoset, R & D, Minneap-
olis, MN).  Procedures were performed according to the 
manufacturer’s instructions. The reaction was detected 
by peroxidase-conjugated streptavidin followed by a 
substrate mixture containing hydrogen peroxide and 
ABTS (Sigma Aldrich, St. Louis, MO) as a chromogen.
Statistical analyses - Regression analysis was used to 
compare antibody and cytokine levels; regression lines 
were compared by analysis of covariance. In all cases, 
differences were considered statistically significant 
when p < 0.05. All analyses were performed using the 
PRISM 3.0 software (GraphPad, San Diego, CA).
RESULTS 
In order to correlate clinical findings with the im-
munological response observed during chronic Chagas 
disease, and to identify potential immunological patho-
genesis markers, circulating cytokine (IL-10 and IFN-γ) 
and IgG isotype (total IgG, IgG1 and IgG2) levels were 
determined in IND and CARD chagasic patients. 
Higher production of total IgG was observed in IND 
(1.26 ± 0.17) and CARD (1.23 ± 0.13) patients compared 
to NI (0.18 ± 0.04, p < 0.05) patients (Fig. 1A). An analy-
sis of the results showed that sera from both IND (0.86 
± 0.23) and CARD (0.88 ± 0.22) patients presented with 
higher levels of T. cruzi-specific IgG1 antibodies than NI 
(0.14 ± 0.03, p < 0.05) patients. However, no difference 
was observed between IND and CARD patients in terms 
of IgG1 production (Fig. 1B). No difference was observed 
in IgG2 levels between IND (0.34 ± 0.14), CARD (0.32 ± 
0.16) and NI (0.23 ± 0.09) individuals (Fig. 1C). 
Statistically similar levels of IL-10 were detected in 
the sera of IND patients (9.48 ± 3.09), CARD chagasic pa-
tients (13.68 ± 2.35) and NI individuals (8.13 ± 3.82) (Fig. 
2). Patients with IND (59.44 ± 18.63) and CARD (80.12 ± 
22.32) forms of Chagas disease, as well as NI individuals 
(53.83 ± 17.41) presented similar IFN-γ levels (Fig. 2). 
In an attempt to clarify the immunoregulatory mech-
anisms involved in the chronic cardiac pathology of 
Chagas disease, our group investigated whether a corre-
lation exists between cytokine and IgG isotype produc-
tion, and between regulatory (IL-10) and inflammatory 
(IFN-γ) cytokine levels in CARD and IND patients. No 
correlation was observed between cytokine (IL-10 and 
IFN-γ) and IgG isotype (IgG1 and IgG2) production (data 
not shown); however, a positive correlation (R = 0.82, 
p < 0.0001) (Fig. 3A) was observed between IFN-γ and 
IL-10 levels in the sera of IND patients. Interestingly, 
an analysis of CARD patients showed no correlation 
(R = 0.11, p = 0.69) between regulatory and inflamma-
tory cytokine production (Fig. 3B).
DISCUSSION
Distinct cytokine profiles exert important influences 
in IgG production, and antibodies are important to con-
trol parasite infection and immunopathological process-
es (Tibbetts et al. 1994). The current results, using total 
epimastigote antigen, showed high levels of IgG1 in cha-
gasic patients compared to non-chagasic individuals and 
similar IgG1 levels in with the IND versus the CARD 
clinical forms. These results are in agreement with data 
that demonstrated high IgG1 concentrations against epi-
mastigote antigen in sera from all groups of chagasic pa-
Fig. 1: Trypanosoma cruzi specific total-IgG (A), IgG1 (B) and IgG2 (C) antibodies in the sera of indeterminate (IND) and cardiac (CARD) 
patients with chronic Chagas disease and noninfected individuals (NI). Asterisks indicate statistic significance for comparisons between NI and 
chagasic patients (IND and CARD) (p < 0.05). Each data point represents the mean absorbance of duplicate wells.
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tients by ELISA, regardless of the clinical form (Cerban 
et al. 1993). High IgG1 and similar IgG3 production in 
patients presenting different clinical forms of the dis-
ease were described using different antigenic prepara-
tions, such as paraflagellar rod protein (Michailowsky 
et al. 2003). Cerban et al. (1993) observed no significant 
differences regarding IgG isotype production in chronic 
chagasic patients with different clinical forms. However, 
a different antigenic recognition pattern by IgG1 among 
different clinical groups by immunoblotting using acidic 
antigenic fraction (AAF) separated from T. cruzi cytosol 
was observed. It seems that some relationship exists be-
tween the pattern of IgG1 reactivity with AAF and the 
degree of heart damage. The distinct production of IgG 
isotypes identified via ELISA was described for chagasic 
patients with different clinical forms of the disease. Anal-
ysis of literature data shows that when using epimastigote 
antigenic preparation, CARD patients produced elevated 
levels of IgG2 compared with the IND and NI groups 
(Morgan et al. 1996). It is possible that the preferential 
induction of different subsets of T helper cells by spe-
cific antigen or host genetic background may be crucial 
to the pattern of antibody response and, subsequently, in 
the immunopathology of Chagas disease. Patients with 
different clinical forms of Chagas disease have the abil-
ity to produce similar antibody levels; therefore, given 
the clinical and immunological differences among the 
groups, it is reasonable to hypothesize that these antibod-
ies may recognize different antigenic targets. 
Cytokine profiling has been demonstrated as fun-
damental to defining the immunopathological mecha-
nisms involved in chronic chagasic cardiomyopathy and 
controlling the immune response during T. cruzi infec-
tion (Zhang & Tarleton 1996). The proinflammatory 
cytokines IL-12, IFN-γ and TNF-α (Th1 response) act 
in concert to activate macrophages to kill the parasites 
through the production of nitric oxide and NO-derived 
nitrogen free radicals. In addition, they also stimulate 
the differentiation and proliferation of Th1-biased CD4 
T cells, which may orchestrate a CD8 T cell response 
that causes tissue destruction and fibrosis (Higuchi et al. 
2003). As expected, this inflammatory response needs 
to be regulated, and this occurs mainly via the action of 
the anti-inflammatory cytokines IL-4, IL-10 and TGF-β 
(Silva et al. 1992, Holscher et al. 1998). Thus, cytokine 
expression may be correlated with clinical manifesta-
tions of disease.
A few studies concerning cytokine sera levels have 
been performed in individuals with different clinical 
forms of Chagas disease and contradictory results were 
obtained. It is possible that the contradictions are due 
to the procedures used for sample collection, which can 
influence the outcome of laboratory measurements. 
This study showed that serum cytokine levels in patients 
with the CARD chronic form of the disease did not dif-
fer from those of IND patients. Thus, the present results 
are in agreement with the finding of Ward et al. (1999) 
that similar levels of IFN-γ and TNF-α can be found 
in the sera of chronic chagasic patients (both IND and 
CARD form) and NI patients. Interestingly, although 
these authors used different collection procedures than 
Fig. 2: IL-10 and IFN-γ quantification by ELISA in the sera of inde-
terminate and cardiac patients with chronic Chagas disease and non 
infected individuals. Results are mean ± standard error medium.
Fig. 3: correlation between IFN-γ and IL-10 levels in the sera of cha-
gasic patients that presented the indeterminate (A) and cardiac (B) 
forms of the disease. Positive correlation was considered significant 
when the p < 0.05. 
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those used by our group, similar results were obtained. 
This implies that other factors, possibly related to the 
patient classification criteria, could also be involved, as 
suggested by Dutra et al. (2005). Similar high levels of 
TNF-α were detected in asymptomatic individuals and 
patients with digestive and CARD clinical forms, respec-
tively (Perez-Fuentes et al. 2007). However, Ferreira et 
al. (2003) showed that patients with significant left ven-
tricular (LV) dysfunction (LV ejection fraction ≤ 50%) 
showed higher levels of TNF-α, compared to chagasic 
patients without LV dysfunction. It has been suggested 
that chronic TNF-α production prior to heart failure may 
play a role in chronic Chagas disease cardiomyopathy 
progression (Ferreira et al. 2003). A similar level of cy-
tokine production in sera of acute chagasic children, 
compared to NI, has been described previously (Moretti 
et al. 2002). Although the present results showed no dif-
ferences between IL-10 and IFN-γ levels in CARD and 
IND patients, the IND patients displayed a positive cor-
relation between inflammatory and regulatory cytokine 
production, indicating a controlled immune response. 
These findings are supported by the higher production 
of IFN-γ and TNF-α associated with high IL-10 levels 
described in IND patients, while CARD patients showed 
an unregulated Th1 response (Bahia-Oliveira et al. 1998, 
Correa-Oliveira et al. 1999, Ribeirao et al. 2000, Abel et 
al. 2001, Gomes et al. 2005). A lack of co-regulation be-
tween inflammatory and anti-inflammatory cytokines 
associated with severe disease was also demonstrated in 
human patients with leishmaniasis (Gaze et al. 2006), 
strengthening this hypothesis.
In conclusion, these findings suggest that no correla-
tion exists between cytokine (IL-10 and IFN-γ) and IgG 
isotype (IgG1 and IgG2) levels in the sera of chagasic pa-
tients with IND and CARD clinical forms of Chagas dis-
ease. However, analysis of the results reinforces the fact 
that more efficient regulation of IFN-γ and IL-10 produc-
tion occurs in IND patients, compared to CARD patients, 
suggesting that the maintenance of a balanced immune 
response is critical for arresting pathology establishment. 
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